Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2021.04.01

Sustainable transformation stemming from the shop floor

Sustainable transformation
stemming from the shop floor

“You’ll never change your life unless you change something you do daily.” This well-known quote by John Maxwell rings true in the context of our shop floor management.

We began with a small pilot of an interactive and inclusive program we call Shop Floor Transformation Initiative (SFTI) in one of our production blocks in December 2018.

SFTI is a ground-up transformation initiative where associates at shopfloor are empowered and engaged as a cross-functional team to achieve collective goals. The program systematizes a set of processes through which team members monitor and self-evaluate their progress towards accomplishing pre-set goals on a daily basis.

The success of the pilot encouraged us to expand the initiative progressively. In the little over two years since inception, SFTI has grown to an organization-wide initiative spanning our entire manufacturing operations across production, engineering, and warehouse, and has also been fully deployed in our R&D Lab operations.

SFTI has made shop-floor communication more regular, focusing on immediate problem solving, providing a platform for setting productivity expectations while keeping our operations audit-ready, and contributing to manufacturing capability and process innovation.

In line with the Kaizen approach, it encourages shop floor associates to share improvement ideas for Efficiency and Productivity Enhancement, Safety Compliance, Upkeep and Maintenance and Harmonized way of working.

The Grass Root Teams identify opportunities for improvement. The Leadership team provides constant support with appropriate rewards and recognition. Housekeeping as per norms makes the location audit-ready at any time.

The upshot of SFTI has been sustained improvement in PQCDSM (Productivity, Quality, Cost, Delivery, Safety and Morale). Further, the Initiative helps to build a culture of flexibility and responsiveness in Manufacturing through implementation of 5S at the Shop Floor, monitoring and correcting abnormalities, unsafe conditions / acts if any, making cGMP observations, recording Batch Cycle Time (BCT), and Batch Charge Frequency (BCF), all of which are critical for productivity enhancement.

Beyond measurable metrics, SFTI imparts intangible, intrinsic values such as a spirit of ownership and collaboration, which are core values at Sai Life Sciences.

Other positive outcomes include effective resource planning and rapid and structured information flow among shop-floor employees. From a Lean manufacturing perspective, benefits include reduction in pending Job Orders through close tracking and monitoring with AET and SET boards, and overall cost improvement.

Watch this video to know more.

Share article

More News

2025.09.05

Reviving Kudikunta Lake: Bringing nature and community closer together

As part of its Corporate Social Responsibility initiative, Sai Life Sciences has taken up the development of Kudikunta Lake in Hyderabad, reinforcing its commitment to sustainability and community well-being. The Kudikunta Lake initiative marks a significant step in restoring one of Hyderabad’s key lakes and advancing the cause of sustainable urban living. The company has […]
Read more

2025.09.05

From injections to pills: oral peptides set to transform drug development

In a recent article published in Drug Target Review, Dr Santosh Kulkarni highlights the shift from injections to pills. He writes about how oral peptide therapeutics are overcoming the long-standing challenge of poor bioavailability—bringing us closer to patient-friendly medicines without compromising efficacy. The article highlights the booming peptide drug market and the scientific advances—from chemical […]
Read more

2025.08.28

Sai Life Sciences completes Phase II of Production Block 11 at Bidar site, India, expands capacity to 700 KL

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the completion of Phase II of its new Production Block (PB-11) at the company’s flagship API manufacturing facility in Bidar, India (Unit IV). The Phase I of PB-11, with a capacity of 110 KL, was inaugurated […]
Read more

2025.08.20

Sai Life Sciences secures SBTi validation for near-term climate targets

Sai Life Sciences Limited, an innovator focused Contract Research, Development, and Manufacturing Organization (CRDMO), announced that its near-term targets to cut greenhouse gas (GHG) emissions have been validated by the Science Based Targets initiative (SBTi)—a corporate climate action organization that enables companies and financial institutions worldwide to play their part in combating the climate crisis. […]
Read more

2025.08.20

Sai Life Sciences featured in Drug Discovery & Development on trends shaping drug discovery

Sai Life Sciences was recently featured in Drug Discovery & Development, where Dr Maneesh Pingle, Executive Vice President and Head of Discovery Services, shared insights on the emerging trends in pharma sector. A key focus was the impact of GLP 1 agonists in accelerating peptide drug discovery. Dr. Pingle explained how the success of these […]
Read more